Shamez Ladhani to Cohort Studies
This is a "connection" page, showing publications Shamez Ladhani has written about Cohort Studies.
Connection Strength
0.182
-
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England. Clin Infect Dis. 2021 03 01; 72(5):e65-e75.
Score: 0.041
-
Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018. Vaccine. 2019 07 26; 37(32):4491-4498.
Score: 0.037
-
Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales. J Infect. 2018 04; 76(4):335-341.
Score: 0.033
-
Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010-2015. Arch Dis Child. 2018 07; 103(7):643-647.
Score: 0.033
-
Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open. 2021 08 26; 11(8):e052838.
Score: 0.011
-
The ability of the neonatal immune response to handle SARS-CoV-2 infection - Authors' reply. Lancet Child Adolesc Health. 2021 03; 5(3):e8.
Score: 0.010
-
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020 08 27; 370:m3249.
Score: 0.010
-
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017 10; 2(10):e473-e482.
Score: 0.008